Delivery Order SPE2DB22D1202-SPE2DB25FVKQ4
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $2,052.63 to AmerisourceBergen Drug Corp on August 18, 2025, for TRELEGY ELLIPTA 100-62.5-25, a respiratory medication supplied in a 60-dose inhaler. This competitively awarded, firm fixed-price contract is classified as a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 vehicle running through December 2026. The place of performance is listed as...
- The Defense Logistics Agency awarded a delivery order valued at $13,390.69 to AmerisourceBergen Drug Corp for TRELEGY ELLIPTA 200-62.5-25 60S, a combination pharmaceutical product used in respiratory disease treatment. This firm fixed-price, non-set-aside delivery order was awarded on August 12, 2025, with an ultimate completion date of August 13, 2025. The contract is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a child delivery order,...
- The Defense Logistics Agency awarded a delivery order valued at $7,937.65 to AmerisourceBergen Drug Corp for TRELEGY ELLIPTA 100-62.5-25, a combination respiratory medication, with a completion date of August 26, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. AmerisourceBergen, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical procurement needs across military and...
- The Defense Logistics Agency awarded a delivery order valued at $12,545.61 to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of Trelegy Ellipta 100-62.5-25, a combination respiratory medication, with an ultimate completion date of August 15, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at...
- The Defense Logistics Agency awarded a delivery order valued at $2,658.71 to AmerisourceBergen Drug Corp for TRELEGY ELLIPTA 100-62.5-25, a respiratory maintenance medication supplied in a 60-dose inhaler configuration. Awarded on July 21, 2025, with completion targeted for July 22, 2025, this firm fixed-price delivery order was competitively awarded with no set-aside designation. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the...
- The Defense Logistics Agency awarded a delivery order valued at $21,739.01 to AmerisourceBergen Drug Corp on August 22, 2025, for the supply of TRELEGY ELLIPTA 200-62.5-25, a combination respiratory medication, with an ultimate completion date of August 25, 2025. This non-set-aside, firm fixed-price delivery order was competitively awarded and is being fulfilled from AmerisourceBergen's place of performance in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a $33,190.95 firm fixed-price delivery order to AmerisourceBergen Drug Corp for TRELEGY ELLIPTA 100-62.5-25, a respiratory medication supplied in a 60-dose inhaler format. This non-set-aside competitive award was executed on August 28, 2025, with an ultimate completion date of August 29, 2025, and is being performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a relatively modest transaction within the...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $98,086.77 for TRELEGY ELLIPTA 200-62.5-25 inhalers (60-count units) on August 20, 2025, with completion scheduled for August 21, 2025. This competitively awarded, firm fixed-price delivery order was placed under a child contract vehicle with no set-aside designation. The pharmaceutical product will be delivered to the place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen maintains...
- The Defense Logistics Agency awarded a delivery order valued at $9,142.14 to AmerisourceBergen Drug Corp for TRELEGY ELLIPTA 200-62.5-25, a combination respiratory maintenance medication, with an ultimate completion date of August 4, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and is classified as a child contract under AmerisourceBergen's larger federal contract vehicle. The place of performance is the vendor's Corporate Office location in...
- The Defense Logistics Agency awarded a delivery order valued at $20,134.28 to AmerisourceBergen Drug Corp for TRELEGY ELLIPTA 100-62.5-25, a combination respiratory medication, with an ultimate completion date of July 28, 2025. This firm fixed price delivery order represents a non-competitive set-aside contract awarded on July 25, 2025, with performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract is issued under the company's larger Indefinite...
- SPE2DB22D1202Indefinite Delivery Contract
- SPE2DB22D1202-SPE2DB25FVKQ4Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,371.72 to AmerisourceBergen Drug Corp for TRELEGY ELLIPTA 200-62.5-25 (a combination respiratory medication) on September 8, 2025, with completion scheduled for September 9, 2025. This competitive award utilizes firm fixed pricing with no set-aside designation and is performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (contract SPE2DX), a $999,999,999 vehicle authorized through December 2026 that serves as a comprehensive global pharmaceutical support contract for military healthcare programs. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, functions as a critical vendor for federal medical procurement through its prime indefinite delivery vehicle with DLA. The SPE2DX contract enables the company to supply a broad range of pharmaceuticals, generic and brand-name medications, vaccines, and medical supplies to support the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems worldwide. This specific delivery order represents a routine small-value pharmaceutical purchase within AmerisourceBergen's substantial federal contract portfolio, demonstrating the company's ongoing role in sustaining military medical supply chains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.4k | 9/8/25 |